SCHEMBL5030653

SCHEMBL5030653

C[C@@H](CI)CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8562131 1.00
SCHEMBL5030656 1.00
SCHEMBL8076557 0.86
SCHEMBL6599315 0.82
SCHEMBL6599313 0.82
SCHEMBL7015469 0.80
SCHEMBL1227142 0.80
SCHEMBL16317827 0.80
SCHEMBL15146208 0.80
SCHEMBL13986795 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003801-B2 Chemical synthesis of a highly potent epothilone THE SCRIPPS RESEARCH INSTITUTE (US) 2011-08-23 US disclosed
US-20080293747-A1 Chemical Synthesis of a Highly Potent Epothilone NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2008-11-27 US disclosed
EP-1939191-A1 Furan derivatives, method of synthesis and uses thereof Neuropharma S.A. (ES) 2008-07-02 EP disclosed
US-6441186-B1 ANTICANCER AGENTS; PREVENTION OF MITOSIS THROUGH INDUCTION AND STABILIZATION OF MICROTUBULIN ASSEMBLY; SUPERIOR CYTOTOXIC ACTIVITIES THE SCRIPPS RESEARCH INSTITUTE 2002-08-27 US disclosed
EP-0871628-A1 QUINOLIZINONE TYPE COMPOUNDS Abbott Laboratories (US) 1998-10-21 EP disclosed
US-5726182-A TREATMENT OF BACTERIAL INFECTIONS ABBOTT LABORATORIES (US) 1998-03-10 US disclosed
US-5599816-A BACTERICIDE ABBOTT LABORATORIES (US) 1997-02-04 US disclosed
WO-1996039407-A1 QUINOLIZINONE TYPE COMPOUNDS ABBOTT LABORATORIES (US) 1996-12-12 WO disclosed
US-5580872-A ADMINISTERING IN THE TREATMENT OF BACTERIAL INFECTIONS ABBOTT LABORATORIES (US) 1996-12-03 US disclosed
EP-0723545-A1 QUINOLIZINONE TYPE COMPOUNDS ABBOTT LABORATORIES (US) 1996-07-31 EP disclosed
WO-1995010519-A1 QUINOLIZINONE TYPE COMPOUNDS ABBOTT LABORATORIES (US) 1995-04-20 WO disclosed